{"result": "(\"entity\"<|>TIROIDES<|>GEO<|>Tiroides refers to the thyroid gland, which is a key focus in discussions about hormonal interactions and conditions like insuficiencia tiroidea.)\n##\n(\"entity\"<|>SUPrARRENAL<|>GEO<|>Suprarrenal refers to the adrenal glands, which are involved in hormonal regulation and are mentioned in the context of endocrine disorders.)\n##\n(\"entity\"<|>GÓNADAS<|>GEO<|>Gónadas refer to the reproductive glands, which are discussed in relation to hormonal interactions and conditions.)\n##\n(\"entity\"<|>HIPÓFISIS<|>GEO<|>Hipófisis refers to the pituitary gland, a crucial part of the endocrine system that regulates various hormones.)\n##\n(\"entity\"<|>CORTISOL<|>EVENT<|>Cortisol is a hormone produced by the adrenal glands, discussed in the context of hormonal interactions and health implications.)\n##\n(\"entity\"<|>ACTH<|>EVENT<|>ACTH (Adrenocorticotropic hormone) is a hormone that stimulates the adrenal glands and is relevant in discussions about hormonal balance.)\n##\n(\"entity\"<|>FT4<|>EVENT<|>FT4 (Free Thyroxine) is a hormone produced by the thyroid gland, significant in the context of thyroid function and disorders.)\n##\n(\"entity\"<|>TSH<|>EVENT<|>TSH (Thyroid-Stimulating Hormone) is a hormone that regulates the thyroid gland and is mentioned in relation to thyroid conditions.)\n##\n(\"entity\"<|>TPO<|>EVENT<|>TPO (Thyroid Peroxidase) is an enzyme involved in thyroid hormone production, relevant in discussions about thyroid health.)\n##\n(\"entity\"<|>TSI<|>EVENT<|>TSI (Thyroid Stimulating Immunoglobulin) is an antibody that can affect thyroid function, mentioned in the context of hyperthyroidism.)\n##\n(\"entity\"<|>FSH<|>EVENT<|>FSH (Follicle-Stimulating Hormone) is a hormone involved in reproductive processes, discussed in relation to gonadal function.)\n##\n(\"entity\"<|>LH<|>EVENT<|>LH (Luteinizing Hormone) is a hormone that plays a role in regulating the reproductive system, relevant in discussions about gonadal health.)\n##\n(\"relationship\"<|>TIROIDES<|>INSUFICIENCIA TIROIDEA<|>Insuficiencia tiroidea is a condition affecting the tiroides, leading to hormonal imbalances<|>8)\n##\n(\"relationship\"<|>SUPrARRENAL<|>CORTISOL<|>Cortisol is produced by the suprarrenal glands, linking them in discussions about hormonal regulation<|>7)\n##\n(\"relationship\"<|>GÓNADAS<|>FSH<|>FSH regulates the function of the gónadas, establishing a relationship in reproductive health<|>6)\n##\n(\"relationship\"<|>GÓNADAS<|>LH<|>LH also regulates the function of the gónadas, further linking them in hormonal discussions<|>6)\n##\n(\"relationship\"<|>HIPÓFISIS<|>ACTH<|>ACTH is produced by the hipófisis and stimulates the suprarrenal glands, linking these entities in hormonal regulation<|>8)\n##\n(\"relationship\"<|>TIROIDES<|>FT4<|>FT4 is a hormone produced by the tiroides, establishing a direct relationship in thyroid function<|>9)\n##\n(\"relationship\"<|>TIROIDES<|>TSH<|>TSH regulates the production of hormones by the tiroides, linking them in discussions about thyroid health<|>9)\n##\n(\"relationship\"<|>TIROIDES<|>TPO<|>TPO is involved in the production of hormones by the tiroides, establishing a relationship in thyroid function<|>8)\n##\n(\"relationship\"<|>TIROIDES<|>TSI<|>TSI can affect the function of the tiroides, particularly in autoimmune conditions<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 2017.02.005\n     ATO: antitiroideo de síntesis; β-bloq: betabloqueante; FC: fLudrocotisona; HC: hidrocortisona; L-tirox: L-tiroxina; metilpred: metilpredni-      • Zarzuelo A. Introducción a las interacciones farmacológicas. En: Zarzuelo A, Utrilla MP, Ocete MA, Martín A, eds. Interacciones\n     solona. v.o.: vía oral; v.p.: vía parenteral.                                                                                                      farmacológicas I. Málaga: Publicaciones Vértice; 2009. p. 7-18.\n\n\n\n     Tabla 9. Endocrinopatías por bloqueo de puntos de control inmunológico (checkpoint).\n     Manejo de alteraciones tiroideas                                                                                                             44  Con respecto         a la hiperuricemia, señale la respuesta                     falsa:\n       ALTERACIÓN                 GLÁNDULA                  HORMONAS                    INMUNIDAD                 CRIBADO                             A. La causa fundamental de la hiperuricemia es por hiperproducción de ácido úrico.\n       Insuficiencia                Tiroides             FT4     N - TSH                     TPO              FT4 - TSH - TPO                         B. El ácido úrico es antioxidante.\n       primaria                 Suprarrenales           CORT     N - ACTH                                    CLU - CORT - ACTH                        C. El ácido úrico es un marcador de riesgo cardiovascular.\n       Diana                                                                         Ac antiadrenales                                                 D.  La hiperuricemia asintomática no debe tratarse.\n                                   Gónadas           TST/E2      N - FSH/LH                                  TST/E2 - FSH - LH\n       Insuficiencia                Tiroides             FT4      - TSH    N                                      FT4 - TSH\n       secundaria               Suprarrenales           CORT      - ACTH     N        Ac antihipófisis       CLU - CORT - ACTH                        COMENTARIO\n       Hipófisis                   Gónadas           TST/E2       - FSH/LH      N                            TST/E2 - FSH - LH                        El ácido úrico es un potente antioxidante extracelular. Se calcula que más de la mitad de la\n       Hiperfunción                 Tiroides             FT4     N - TSH                     TSI               FT4 - TSH - TSI                        capacidad antioxidante de nuestro organismo proviene del ácido úrico. No obstante, a nivel\n       Enf. no tiroidea             Tiroides          TT4 - FT4      - TSH    N                                   FT4 - TSH                           intracelular puede inducir estrés oxidativo en ciertas células, por la generación de radicales\n                                                                                                                                                      libres, y por ello asociarse a un aumentado riesgo cardiovascular.\n       : alto; : bajo; N: normal.\n                                                                                                                                                      La hiperuricemia puede ser consecuencia de un aumento de la producción de ácido úrico,\n                                                                                                                                                      una disminución de su eliminación o por ambos procesos.\n                                                                                                                                                      Más de 90% de las personas con hiperuricemia mantenida presentan una alteración de\n                                                                                                                                                      la eliminación renal del ácido úrico.\n                                                                                                                                                      La hiperuricemia mantenida predispone en ciertas personas a padecer patologías por\n                                                                                                                                                      depósito de cristales de urato o ácido úrico (artritis gotosa, urolitiasis o nefropatía), pero\n                                                                                                                                                      la mayoría son asintomáticos, y en estos no                      hay indicación        específica para recibir trata-\n                                                                                                                                                      miento. Es más, no se recomienda la detección sistemática de hiperuricemia asintomática.\n\n\n\n366                                                                                                                                                                                                                                                                                      367\n---\n                                                                                                                                                                       GÓNADAS,               SÍNDROME POLIGLANDULAR                                                6\n                                                                                                                                                                                           AUTOINMUNE Y                      MISCELÁNEA\n\n\n\n         Solo se plantea el tratamiento en ciertos casos de pacientes que reciben tratamiento citolí-                                            elevados     de fenilalanina      en sangre     durante     el embarazo,      e  incluyen retraso del creci-\n         tico por enfermedad neoplásica, para prevenir la nefropatía por ácido úrico.                                                            miento intrauterino, retraso mental, microcefalia, alteraciones faciales y malformacio-\n         La   hiperuricemia      asintomática se asocia con hipertensión,                 enfermedad       renal   crónica,                      nes cardiacas. El riesgo de anomalías depende de la concentración materna de fenilala-\n         enfermedad        cardiovascular      y  síndrome metabólico,           aunque     no   está  demostrada        una                     nina en sangre y es independiente de si el feto padece la enfermedad o tiene la alteración\n         relación causal.       Por tanto, la hiperuricemia se puede considerar un marcador de riesgo                                            genética.\n         cardiovascular y su        hallazgo debe intensificar en el paciente las              medidas     de   prevención                       La concentración sérica elevada de fenilalanina durante el embarazo temprano en una ma-\n         cardiovascular. No obstante, la\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ZARZUELO A<|>PERSON<|>Zarzuelo A is an author who contributed to the work on pharmacological interactions and is involved in the field of endocrinology.)\n##\n(\"entity\"<|>MÁLAGA<|>GEO<|>Málaga is a city in Spain where the publication on pharmacological interactions was released.)\n##\n(\"entity\"<|>PUBLICACIONES VÉRTICE<|>ORGANIZATION<|>Publicaciones Vértice is the publishing house that published the work on pharmacological interactions in Málaga in 2009.)\n##\n(\"entity\"<|>HORMONAS<|>EVENT<|>The discussion of hormones in the context of pharmacological interactions is a significant event in endocrinology.)\n##\n(\"entity\"<|>INSUFICIENCIA TIROIDEA<|>EVENT<|>Insuficiencia tiroidea refers to thyroid insufficiency, a condition discussed in the context of hormonal interactions.)\n##\n(\"entity\"<|>HIPERURICEMIA<|>EVENT<|>Hiperuricemia is a medical condition discussed in the text, associated with various health risks.)\n##\n(\"relationship\"<|>ZARZUELO A<|>PUBLICACIONES VÉRTICE<|>Zarzuelo A authored a work published by Publicaciones Vértice on pharmacological interactions<|>8)\n##\n(\"relationship\"<|>PUBLICACIONES VÉRTICE<|>MÁLAGA<|>Publicaciones Vértice is located in Málaga, where the pharmacological interactions work was published<|>6)\n##\n(\"relationship\"<|>INSUFICIENCIA TIROIDEA<|>HORMONAS<|>Insuficiencia tiroidea is related to hormonal discussions in the context of pharmacological interactions<|>7)\n##\n(\"relationship\"<|>HIPERURICEMIA<|>HORMONAS<|>Hiperuricemia is discussed in relation to hormonal balance and its implications for health<|>5)\n<|COMPLETE|>"}]}